WEBSITECHANGES

Website Changes

---

07/24/2017

Novocure™ Announces a Phase 1b Clinical Trial to Evaluate the Safety of Marizomib and Temozolomide in Combination with Optune® as Adjuvant Therapy in Patients with Glioblastoma

---

07/23/2017

Glioblastoma: New tools against brain cancer

---

07/22/2017

The Musella Foundation has awarded a pediatric brain tumor research grant

---

07/20/2017

Camp Jinka is a free summer program for kids and teens whose lives have been impacted by the diagnosis of a brain tumor .

---

07/19/2017

Human CAR-T Cell Glioblastoma Trial Generates Clues for Improving Treatment

---

07/19/2017

The Cedars-Sinai Department of Neurosurgery Presents Outsmarting Brain Tumors: A Conference on Brain Tumors for Patients, Families and Caregivers

---

07/19/2017

HOW NOT TO DIE: ‘STUPID CANCER’ COMMUNITY HELPS ANGRY YOUNG PEOPLE LIVE

---

07/06/2017

Comparative Study of Adjuvant Temozolomide Six Cycles Versus Extended 12 Cycles in Newly Diagnosed Glioblastoma Multiforme.

---

07/06/2017

Optimizing bevacizumab dosing in glioblastoma: less is more.

---

07/06/2017

Extent of resection and Carmustine wafer implantation safely improve survival in patients with a newly diagnosed glioblastoma: a single center experience of the current practice.

---

06/24/2017

No measurable gadolinium in children’s brains even after multiple doses

---

06/23/2017

Musella Foundation (and our copay assistance program) will be closed the week of June 25- July 3

---

06/21/2017

Cash-strapped ImmunoCellular halts brain cancer vaccine trial, eyes `strategic alternatives`

---

06/21/2017

Looking Ahead: Combination Offers New Hope For Glioblastoma

---

06/18/2017

Diffusion Pharmaceuticals seeks Wall Street investment while staying local

---

06/17/2017

A Nontoxic Pill to Replace Chemotherapy? It’s Possible

---

06/16/2017

Researchers assess pinworm medication for adults, children with glioblastoma

---

06/12/2017

First Patient Enrolled in RTOG Trial of Optune® together with Bevacizumab for Patients with Bevacizumab-Refractory Recurrent Glioblastoma

---

06/08/2017

FDA has approved Gleolan

---

06/07/2017

Medicenna’s Immunotherapy Phase 2b Trial Underway Using Brainlab Drug Delivery Technology

---

06/07/2017

Five years before brain cancer diagnosis, changes detectable in blood

---

06/07/2017

New Target Found to Attack an Incurable Brain Tumor in Children

---

06/07/2017

Estimating the annual frequency of synchronous brain metastasis in the United States 2010–2013: a population-based study

---

06/01/2017

---

05/30/2017

Efficacy Results for ONC201 in Recurrent Glioblastoma Published

---